Literature DB >> 28688730

Use of Medical Orders for Scope of Treatment for Heart Failure Patients During Postacute Care in Skilled Nursing Facilities.

Hillary Lum1, Oluyomi Obafemi2, Joanna Dukes3, Molly Nowels4, Kristina Samon5, Rebecca S Boxer6.   

Abstract

BACKGROUND: Individuals with heart failure (HF) who are hospitalized and admitted to skilled nursing facilities (SNFs) are at high risk for rehospitalization and death. The care preferences of this high-risk population have not been studied.
OBJECTIVES: To describe care preferences of patients with HF admitted to SNFs for rehabilitation based on Medical Orders for Scope of Treatment (MOST) documentation, and evaluate goal-concordant care based on MOST documentation, emergency department (ED) visits, and hospitalization. DESIGN, SETTING, AND PARTICIPANTS: Retrospective study of patients with HF in 35 SNFs enrolled in a randomized controlled trial of HF-disease management versus usual care between July 2014 and May 2016. MEASUREMENTS: Validity of MOST forms, care preference documentation, and ED visits/hospitalizations within 60 days of SNF admission.
RESULTS: Of 370 patients (mean age 78.6 years, 58% women, 25% systolic HF), 278 (75%) had a MOST form in the SNF chart, of which 96 forms (35%) were invalid. The most common reason for an invalid MOST form was missing date accompanying patient or provider signature. Of 182 valid MOST forms, 47% of patients chose no cardiopulmonary resuscitation ("No CPR"), 58% selected "Full Treatment," 17% chose "Selective Treatment," and 23% chose "Comfort-Focused Treatment." Patients who were older [odds ratio (OR) = 1.50, 95% confidence interval (CI) = 1.25, 1.81] and female (OR = 2.33, 95% CI = 1.18, 4.59) had higher odds of choosing "No CPR." Sixty-six of 182 patients (36%) with valid MOST forms had an ED/hospital visit within 60 days of SNF admission; only 3 patients received medical care that was potentially discordant: all 3 chose "Comfort-Focused Treatment" and were hospitalized for more than symptom management.
CONCLUSION: Seventy-five percent of patients with HF admitted to SNFs had care preferences documented using the MOST form, and 95% received goal-concordant care based on care preferences documented during the SNF admission. Clinicaltrials.gov # NCT01822912.
Copyright © 2017 AMDA – The Society for Post-Acute and Long-Term Care Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  POLST; advance directives; goal-concordant care; heart failure; skilled nursing facility; subacute rehabilitation

Mesh:

Year:  2017        PMID: 28688730      PMCID: PMC5730449          DOI: 10.1016/j.jamda.2017.05.021

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN: 1525-8610            Impact factor:   4.669


  16 in total

1.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

2.  Physician orders for life-sustaining treatment (POLST): lessons learned from analysis of the Oregon POLST Registry.

Authors:  Terri A Schmidt; Dana Zive; Erik K Fromme; Jennifer N B Cook; Susan W Tolle
Journal:  Resuscitation       Date:  2014-01-06       Impact factor: 5.262

3.  Nursing Home Residents' Preferences on Physician Orders for Life Sustaining Treatment.

Authors:  Anna N Rahman; Matthew Bressette; Zachary D Gassoumis; Susan Enguidanos
Journal:  Gerontologist       Date:  2015-03-20

4.  Quality of Physician Orders for Life-Sustaining Treatment Forms Completed in Nursing Homes.

Authors:  Anna N Rahman; Matthew Bressette; Susan Enguidanos
Journal:  J Palliat Med       Date:  2016-11-14       Impact factor: 2.947

5.  Use of the Physician Orders for Life-Sustaining Treatment program for patients being discharged from the hospital to the nursing facility.

Authors:  Susan E Hickman; Christine A Nelson; Esther Smith-Howell; Bernard J Hammes
Journal:  J Palliat Med       Date:  2013-12-18       Impact factor: 2.947

6.  Discharge to a skilled nursing facility and subsequent clinical outcomes among older patients hospitalized for heart failure.

Authors:  Larry A Allen; Adrian F Hernandez; Eric D Peterson; Lesley H Curtis; David Dai; Frederick A Masoudi; Deepak L Bhatt; Paul A Heidenreich; Gregg C Fonarow
Journal:  Circ Heart Fail       Date:  2011-03-29       Impact factor: 8.790

7.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

8.  Sex differences in creation of do-not-resuscitate orders for critically ill elderly patients following emergency surgery.

Authors:  Soumitra R Eachempati; Lynn Hydo; Jian Shou; Philip S Barie
Journal:  J Trauma       Date:  2006-01

9.  End-of-life care in patients with heart failure.

Authors:  David J Whellan; Sarah J Goodlin; Michael G Dickinson; Paul A Heidenreich; Connie Jaenicke; Wendy Gattis Stough; Michael W Rich
Journal:  J Card Fail       Date:  2014-02       Impact factor: 5.712

10.  Sex differences in the use of early do-not-resuscitate orders after intracerebral hemorrhage.

Authors:  Kazuma Nakagawa; Megan A Vento; Todd B Seto; Matthew A Koenig; Susan M Asai; Cherylee W J Chang; J Claude Hemphill
Journal:  Stroke       Date:  2013-08-27       Impact factor: 7.914

View more
  2 in total

1.  The influence of POLST on treatment intensity at the end of life: A systematic review.

Authors:  Kelly C Vranas; Wesley Plinke; Donald Bourne; Devan Kansagara; Robert Y Lee; Erin K Kross; Christopher G Slatore; Donald R Sullivan
Journal:  J Am Geriatr Soc       Date:  2021-09-22       Impact factor: 7.538

2.  The Medical Orders for Scope of Treatment (MOST) form completion: a retrospective study.

Authors:  Anastasia A Mallidou; Coby Tschanz; Elisabeth Antifeau; Kyoung Young Lee; Jenipher Kayuni Mtambo; Holly Heckl
Journal:  BMC Health Serv Res       Date:  2022-09-22       Impact factor: 2.908

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.